What makes an epidemic newsworthy? Can biotech succession succeed? And what’s so novel about digital health?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, our colleague Matthew Herper joins us to talk about the executive shakeup at Vertex Pharmaceuticals, a company that went from the brink of extinction to biotech dominance. Then, we’ll talk about the dawn of the digital health IPO and what it means for a nascent space. Finally, STAT’s Helen Branswell stops by to explain why the latest Ebola virus outbreak hasn’t made nearly as many headlines as the last one.
For more on what we cover, here’s the Vertex news; here’s the latest on digital health IPOs; and here’s more on Ebola.
We’ll be back next Thursday evening — and every Thursday evening — so be sure to sign up on iTunes, Stitcher, Google Play, or wherever you get your podcasts.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].